Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors

Launched by SYKEHUSET I VESTFOLD HF · Jan 3, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a specific type of surgery called D3 lymphadenectomy for patients with small bowel tumors, including small bowel cancer and carcinoid tumors. The goal is to find out if this surgery is safe and effective, especially since there is some debate among doctors about the best surgical techniques for these types of tumors. The study is currently recruiting participants, and it welcomes individuals aged 65 to 74, regardless of gender.

To join the trial, patients need to be able to understand and sign an informed consent form, which explains the study and its implications. They must have a confirmed diagnosis of a tumor in the small bowel or its surrounding area, and they should be fit for general anesthesia. However, those with certain types of benign tumors or widespread lymphoma are not eligible. Participants can expect to undergo the surgery and will be followed up to monitor their recovery and health outcomes. This trial represents an important step in understanding how to better treat small bowel tumors and improve patients' quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients included must be able to fill in an informed, written consent and to understand its implications and contents and to participate in the follow-up
• • Radiologically/scintigraphically/histologically verified extraduodenal tumor(-s) in the small bowel and/or in the mesentery of the small bowel
• • No signs of inoperability
• • Fit for general anesthetics
• Exclusion Criteria:
• • Extraduodenal small bowel tumors verified as GIST or benign tumor
• • Widespread lymphoma